VOLPENGO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 371
EU - Europa 214
AS - Asia 112
AF - Africa 5
OC - Oceania 3
SA - Sud America 2
Totale 707
Nazione #
US - Stati Uniti d'America 369
CN - Cina 59
IT - Italia 58
AT - Austria 29
SG - Singapore 27
FR - Francia 26
SE - Svezia 25
IE - Irlanda 19
UA - Ucraina 17
DE - Germania 11
VN - Vietnam 10
FI - Finlandia 8
PL - Polonia 6
SN - Senegal 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
GB - Regno Unito 4
JP - Giappone 4
AU - Australia 3
ID - Indonesia 3
IL - Israele 3
BR - Brasile 2
CA - Canada 2
HK - Hong Kong 2
IN - India 2
NL - Olanda 2
GR - Grecia 1
KR - Corea 1
TR - Turchia 1
Totale 707
Città #
Chandler 54
Beijing 38
Fremont 28
Vienna 27
Singapore 24
Ashburn 19
Dublin 19
Torino 19
Dearborn 18
Santa Clara 18
Nyköping 15
Villeurbanne 15
Ann Arbor 11
Wilmington 10
Fairfield 8
Houston 8
Jacksonville 8
Medford 8
Pisa 8
Columbus 6
Princeton 6
Redwood City 6
Woodbridge 5
Düsseldorf 4
San Jose 4
Warsaw 4
Cambridge 3
Dong Ket 3
Duncan 3
Hefei 3
Jakarta 3
Shanghai 3
Venice 3
Boardman 2
Chengdu 2
Fuzhou 2
Gdynia 2
Los Angeles 2
Montigny-le-bretonneux 2
Nutley 2
Piossasco 2
Rome 2
Saint-Fons 2
San Mateo 2
Seattle 2
Tel Aviv 2
Tianjin 2
Toronto 2
Turin 2
Wuhan 2
Adelaide 1
Amsterdam 1
Basel 1
Boston 1
Brescia 1
Bronx 1
Carol Stream 1
Central 1
Costa Mesa 1
Easton 1
Esslingen am Neckar 1
Guangzhou 1
Göttingen 1
Haifa 1
Hong Kong 1
Izmir 1
Jersey City 1
Jinan 1
Nanchang 1
Nanjing 1
New Haven 1
New York 1
Norwalk 1
Prague 1
Recife 1
Sydney 1
São Paulo 1
Venezia 1
Washington 1
Zurich 1
Totale 475
Nome #
Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes 218
COMPARISON OF DROPLET DIGITAL PCR AND STANDARD PCR IN CHRONIC MYELOID LEUKEMIA PATIENTS IN MR4 118
TFR2 AND EpoR EXPRESSION AT DIAGNOSIS AS POSSIBLE PREDICTORS OF ERYTHROPOIETIN TREATMENT RESPONSE IN MDS PATIENTS 114
ANALYSIS OF IRON METABOLISM IN TFR2 TARGETED ANIMALS BRAIN 113
EARLY BCR-ABL REDUCTION IS PREDICTIVE OF BETTER EVENT FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA NEWLY DIAGNOSED PATIENTS TREATED WITH ANY TKIS 96
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor 75
Totale 734
Categoria #
all - tutte 2.154
article - articoli 0
book - libri 0
conference - conferenze 1.340
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.494


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 17 7 0 7 6 4 3
2020/202183 4 7 3 2 16 2 8 2 4 1 15 19
2021/202271 5 2 1 4 2 0 6 0 3 3 32 13
2022/2023135 12 14 2 26 7 30 3 13 12 6 7 3
2023/202451 4 17 3 2 8 7 0 5 0 2 0 3
2024/202570 1 9 3 19 31 7 0 0 0 0 0 0
Totale 734